{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:00:53Z","timestamp":1793397653520,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004681","name":"Higher Education Commission, Pakistan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004681","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.bioorg.2020.104554","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T02:52:37Z","timestamp":1608087157000},"page":"104554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"special_numbering":"C","title":["Probing 4-(diethylamino)-salicylaldehyde-based thiosemicarbazones as multi-target directed ligands against cholinesterases, carbonic anhydrases and \u03b1-glycosidase enzymes"],"prefix":"10.1016","volume":"107","author":[{"given":"Sadaf","family":"Hashmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samra","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahid","family":"Shafiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parham","family":"Taslimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhamamd","family":"Ishaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nastaran","family":"Sadeghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halide Sedef","family":"Karaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naeem","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhamamd","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asnuzilawati","family":"Asari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habsah","family":"Mohamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130lhami","family":"Gul\u00e7in","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2020.104554_b0005","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.chempr.2018.01.012","article-title":"Bioactive compound collections: from design to target identification","volume":"4","author":"Laraia","year":"2018","journal-title":"Chem"},{"key":"10.1016\/j.bioorg.2020.104554_b0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/17460441.2018.1413089","article-title":"Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery","volume":"13","author":"Ravikumar","year":"2018","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2020.104554_b0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40169-017-0181-2","article-title":"A perspective on multi-target drug discovery and design for complex diseases","volume":"7","author":"Ramsay","year":"2018","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bioorg.2020.104554_b0020","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.lfs.2018.06.025","article-title":"Novel multi-target directed ligand-based strategies for reducing neuroinflammation in Alzheimer's disease","volume":"207","author":"Wenzel","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2020.104554_b0025","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1089\/ars.2017.7487","article-title":"Anticancer thiosemicarbazones: chemical properties, interaction with iron metabolism, and resistance development","volume":"30","author":"Heffeter","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bioorg.2020.104554_b0030","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2174\/156802611794785190","article-title":"The medicinal chemistry of novel iron chelators for the treatment of cancer","volume":"11","author":"Kovacevic","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0035","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.ejmech.2017.08.021","article-title":"A novel class of thiosemicarbazones show multi-functional activity for the treatment of Alzheimer's disease","volume":"139","author":"Palanimuthu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0040","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1021\/jm900552r","article-title":"Thiosemicarbazones from the old to new: iron chelators that are more than just ribonucleotide reductase inhibitors","volume":"52","author":"Yu","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0045","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1080\/00397911.2019.1626893","article-title":"Efficient synthesis and anti-bovine viral diarrhea virus evaluation of 5-(aryldiazo) salicylaldehyde thiosemicarbazone derivatives","volume":"49","author":"Abbas","year":"2019","journal-title":"Synth. Commun."},{"key":"10.1016\/j.bioorg.2020.104554_b0050","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1039\/C5NJ02822A","article-title":"Synthesis, spectroscopy, structures and antimicrobial activity of mixed-ligand zinc (II) complexes of 5-nitro-salicylaldehyde thiosemicarbazones","volume":"40","author":"Indoria","year":"2016","journal-title":"New J. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0055","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1016\/j.bmc.2008.03.006","article-title":"Novel thiosemicarbazone derivatives as potential antitumor agents: synthesis, physicochemical and structural properties, DNA interactions and antiproliferative activity","volume":"16","author":"Piantanida","year":"2008","journal-title":"Bioorganic Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0060","first-page":"1121","article-title":"Study on the synthesis and bioactivity of arylazo-salicylaldehyde thiosemicarbazone derivatives","volume":"27","author":"Wei","year":"2007","journal-title":"Chinese J. Org. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0065","series-title":"Synthesis, Characterization and Biological Activity of Salicylaldehyde-Thiosemicarbazone and Its Metal Complexes, in","author":"Suliman","year":"2016"},{"key":"10.1016\/j.bioorg.2020.104554_b0070","doi-asserted-by":"crossref","unstructured":"K.G. Yiannopoulou, S.G. Papageorgiou, current and future treatments in alzheimer disease: an update, J. Central Nervous Syst. Disease 12 (2020) 1179573520907397.","DOI":"10.1177\/1179573520907397"},{"key":"10.1016\/j.bioorg.2020.104554_b0075","doi-asserted-by":"crossref","unstructured":"M. Prince, R. Bryce, E. Albanese, A. Wimo, W. Ribeiro, C.P. Ferri, The global prevalence of dementia: a systematic review and metaanalysis, Alzheimer's Dementia 9 (2013) 63\u201375. e62.","DOI":"10.1016\/j.jalz.2012.11.007"},{"key":"10.1016\/j.bioorg.2020.104554_b0080","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2174\/1568026619666190128125912","article-title":"Target enzyme in Alzheimer\u2019s disease: acetylcholinesterase inhibitors","volume":"19","author":"Saxena","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0085","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/1389203720666191107094949","article-title":"Butyrylcholinesterase: a multifaceted pharmacological target and tool","volume":"21","author":"Ha","year":"2020","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.bioorg.2020.104554_b0090","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm7009364","article-title":"Multi-target-directed ligands to combat neurodegenerative diseases","volume":"51","author":"Cavalli","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0095","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/cmdc.201600161","article-title":"Multitarget drug discovery and polypharmacology","volume":"11","author":"Bolognesi","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2020.104554_b0100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-6147(02)01899-0","article-title":"Carbonic anhydrase gating of attention: memory therapy and enhancement","volume":"23","author":"Sun","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2020.104554_b0105","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3109\/14756366.2015.1014476","article-title":"The human carbonic anhydrase isoenzymes I and II (hCA I and II) inhibition effects of trimethoxyindane derivatives","volume":"31","author":"Taslimi","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0110","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1080\/14756366.2018.1564045","article-title":"Novel 2-indolinones containing a sulfonamide moiety as selective inhibitors of candida \u03b2-carbonic anhydrase enzyme","volume":"34","author":"Akdemir","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bioorg.2018.10.012","article-title":"Synthesis, characterization, crystal structure of the coordination polymer Zn (II) with thiosemicarbazone of glyoxalic acid and their inhibitory properties against some metabolic enzymes","volume":"83","author":"Huseynova","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0120","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/14756366.2016.1235042","article-title":"Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors","volume":"32","author":"Melis","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0125","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3390\/ijms17071150","article-title":"Non-classical inhibition of carbonic anhydrase","volume":"17","author":"Lomelino","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2020.104554_b0130","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/14756366.2019.1705291","article-title":"Development of a cheminformatics platform for selectivity analyses of carbonic anhydrase inhibitors","volume":"35","author":"Poli","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0135","doi-asserted-by":"crossref","unstructured":"C.T. Supuran, Carbonic anhydrases and metabolism, in, Multidisciplinary Digital Publishing Institute, 2018.","DOI":"10.3390\/metabo8020025"},{"key":"10.1016\/j.bioorg.2020.104554_b0140","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.3390\/ijms21093165","article-title":"Type 3 diabetes and its role implications in Alzheimer\u2019s disease","volume":"21","author":"Nguyen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2020.104554_b0145","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/193229680800200619","article-title":"Alzheimer's disease is type 3 diabetes\u2014evidence reviewed","volume":"2","author":"De la Monte","year":"2008","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.bioorg.2020.104554_b0150","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s11030-018-9835-2","article-title":"Synthesis, in vitro alpha-glucosidase inhibitory activity, and in silico study of (E)-thiosemicarbazones and (E)-2-(2-(arylmethylene) hydrazinyl)-4-arylthiazole derivatives","volume":"22","author":"Ali","year":"2018","journal-title":"Mol. Diversity"},{"key":"10.1016\/j.bioorg.2020.104554_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2019.127082","article-title":"Novel zinc compound with thiosemicarbazone of glyoxylic acid: synthesis, crystal structure, and bioactivity properties","volume":"1200","author":"Huseynova","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2020.104554_b0160","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.molstruc.2019.04.082","article-title":"New thiosemicarbazide-1, 2, 3-triazole hybrids as potent \u03b1-glucosidase inhibitors: design, synthesis, and biological evaluation","volume":"1192","author":"Bakherad","year":"2019","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2020.104554_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103404","article-title":"Synthesis, characterization and molecular docking of some novel hydrazonothiazolines as urease inhibitors","volume":"94","author":"Shehzad","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0170","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.bioorg.2018.11.053","article-title":"Xanthenone-based hydrazones as potent \u03b1-glucosidase inhibitors: synthesis, solid state self-assembly and in silico studies","volume":"84","author":"Malik","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0175","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.molstruc.2017.04.093","article-title":"Synthesis, structural, DFT studies, docking and antibacterial activity of a xanthene based hydrazone ligand","volume":"1143","author":"Naseem","year":"2017","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2020.104554_b0180","doi-asserted-by":"crossref","first-page":"9351","DOI":"10.1039\/C5NJ01879J","article-title":"Me 3 N-promoted synthesis of 2, 3, 4, 4 a-tetrahydroxanthen-1-one: preparation of thiosemicarbazone derivatives, their solid state self-assembly and antimicrobial properties","volume":"39","author":"Hameed","year":"2015","journal-title":"New J. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0185","doi-asserted-by":"crossref","unstructured":"M.T. Shehzad, A. Imran, G.S.S. Njateng, A. Hameed, M. Islam, M. al-Rashida, M. Uroos, A. Asari, Z. Shafiq, J. Iqbal, Benzoxazinone-thiosemicarbazones as antidiabetic leads via aldose reductase inhibition: Synthesis, biological screening and molecular docking study, Bioorg. Chem. 87 (2019) 857\u2013866.","DOI":"10.1016\/j.bioorg.2018.12.006"},{"key":"10.1016\/j.bioorg.2020.104554_b0190","doi-asserted-by":"crossref","first-page":"63886","DOI":"10.1039\/C6RA12827K","article-title":"Coumarin-based thiosemicarbazones as potent urease inhibitors: synthesis, solid state self-assembly and molecular docking","volume":"6","author":"Hameed","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2020.104554_b0195","doi-asserted-by":"crossref","unstructured":"M.T. Shehzad, A. Hameed, M. al-Rashida, A. Imran, M. Uroos, A. Asari, H. Mohamad, M. Islam, S. Iftikhar, Z. Shafiq, Exploring antidiabetic potential of adamantyl-thiosemicarbazones via aldose reductase (ALR2) inhibition, Bioorg. Chem. 92 (2019) 103244.","DOI":"10.1016\/j.bioorg.2019.103244"},{"key":"10.1016\/j.bioorg.2020.104554_b0200","doi-asserted-by":"crossref","unstructured":"A. Hameed, K.M. Khan, S.T. Zehra, R. Ahmed, Z. Shafiq, S.M. Bakht, M. Yaqub, M. Hussain, A.d.l.V. de Le\u00f3n, N. Furtmann, Synthesis, biological evaluation and molecular docking of N-phenyl thiosemicarbazones as urease inhibitors, Bioorg. Chem. 61 (2015) 51\u201357.","DOI":"10.1016\/j.bioorg.2015.06.004"},{"key":"10.1016\/j.bioorg.2020.104554_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.127922","article-title":"Synthesis and urease inhibitory activity of 1, 4-benzodioxane-based thiosemicarbazones: biochemical and computational approach","volume":"1209","author":"Shehzad","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2020.104554_b0210","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bioorg.2019.03.008","article-title":"Synthesis and characterization of new thiosemicarbazones, as potent urease inhibitors: In vitro and in silico studies","volume":"87","author":"Islam","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103017","article-title":"Synthesis and biological evaluation of bromophenol derivatives with cyclopropyl moiety: ring opening of cyclopropane with monoester","volume":"89","author":"Boztas","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103134","article-title":"Novel 2-aminopyridine liganded Pd (II) N-heterocyclic carbene complexes: synthesis, characterization, crystal structure and bioactivity properties","volume":"91","author":"Erdemir","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0225","doi-asserted-by":"crossref","first-page":"1800359","DOI":"10.1002\/ardp.201800359","article-title":"Synthesis, characterization, molecular docking and biological activities of novel pyrazoline derivatives","volume":"352","author":"Turkan","year":"2019","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2020.104554_b0230","article-title":"Novel eugenol bearing oxypropanolamines: synthesis, characterization, antibacterial, antidiabetic, and anticholinergic potentials","volume":"88","author":"Bilgi\u00e7li","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0235","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.12776","article-title":"Phytochemical content, antioxidant activity, and enzyme inhibition effect of Salvia eriophora Boiss. & Kotschy against acetylcholinesterase, \u03b1-amylase, butyrylcholinesterase, and \u03b1-glycosidase enzymes","volume":"43","author":"Bursal","year":"2019","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.bioorg.2020.104554_b0240","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00706-019-2350-z","volume":"150","author":"Kocyigit","year":"2019","journal-title":"Monatshefte f\u00fcr Chemie-Chemical Monthly"},{"key":"10.1016\/j.bioorg.2020.104554_b0245","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.12720","article-title":"The effects of hesperidin on sodium arsenite-induced different organ toxicity in rats on metabolic enzymes as antidiabetic and anticholinergics potentials: a biochemical approach","volume":"43","author":"Caglayan","year":"2019","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.bioorg.2020.104554_b0250","doi-asserted-by":"crossref","first-page":"1800317","DOI":"10.1002\/ardp.201800317","article-title":"Synthesis, crystal structure, and biological evaluation of optically active 2-amino-4-aryl-7, 7-dimethyl-5-oxo-5, 6, 7, 8-tetrahydro-4H-chromen-3-carbonitriles: Antiepileptic, antidiabetic, and anticholinergics potentials","volume":"352","author":"Maharramov","year":"2019","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2020.104554_b0255","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.sajb.2018.04.001","article-title":"Screening the in vitro antioxidant, antimicrobial, anticholinesterase, antidiabetic activities of endemic Achillea cucullata (Asteraceae) ethanol extract","volume":"120","author":"Eruygur","year":"2019","journal-title":"S. Afr. J. Bot."},{"key":"10.1016\/j.bioorg.2020.104554_b0260","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2020.104554_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102980","article-title":"Synthesis of oxazolidinone from enantiomerically enriched allylic alcohols and determination of their molecular docking and biologic activities","volume":"88","author":"Atmaca","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0270","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1039\/C5CC01854D","article-title":"X-ray crystallography-promoted drug design of carbonic anhydrase inhibitors","volume":"51","author":"Ivanova","year":"2015","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2020.104554_b0275","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bioorg.2018.12.012","article-title":"The first synthesis, carbonic anhydrase inhibition and anticholinergic activities of some bromophenol derivatives with S including natural products","volume":"85","author":"Bayrak","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103213","article-title":"Pyrazole [3, 4-d] pyridazine derivatives: Molecular docking and explore of acetylcholinesterase and carbonic anhydrase enzymes inhibitors as anticholinergics potentials","volume":"92","author":"Taslimi","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103096","article-title":"The green synthesis and molecular docking of novel N-substituted rhodanines as effective inhibitors for carbonic anhydrase and acetylcholinesterase enzymes","volume":"90","author":"Bayindir","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111698","article-title":"Continued exploration and tail approach synthesis of benzenesulfonamides containing triazole and dual triazole moieties as carbonic anhydrase I, II, IV and IX inhibitors","volume":"183","author":"Vats","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0295","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00044-019-02329-1","article-title":"Activation and inhibition effects of some natural products on human cytosolic CAI and CAII","volume":"28","author":"Adem","year":"2019","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2020.104554_b0300","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/17460441.2017.1253677","article-title":"Advances in structure-based drug discovery of carbonic anhydrase inhibitors","volume":"12","author":"Supuran","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2020.104554_b0305","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1021\/ml400304w","article-title":"Structures of human acetylcholinesterase bound to dihydrotanshinone I and territrem B show peripheral site flexibility","volume":"4","author":"Cheung","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104554_b0310","article-title":"Synthesis, bioactivity and binding energy calculations of novel 3-ethoxysalicylaldehyde based thiosemicarbazone derivatives","volume":"103924","author":"Ishaq","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0315","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/acs.jmedchem.7b01086","article-title":"The magic of crystal structure-based inhibitor optimization: development of a butyrylcholinesterase inhibitor with picomolar affinity and in vivo activity","volume":"61","author":"Kosak","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0320","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1021\/bi9016457","article-title":"New glucosidase inhibitors from an ayurvedic herbal treatment for type 2 diabetes: structures and inhibition of human intestinal maltase-glucoamylase with compounds from Salacia reticulata","volume":"49","author":"Sim","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2020.104554_b0325","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.phytol.2013.08.005","article-title":"\u03b1-Glucosidase inhibitory constituents from Chrozophora plicata","volume":"6","author":"Tabussum","year":"2013","journal-title":"Phytochem. Lett."},{"key":"10.1016\/j.bioorg.2020.104554_b0330","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/S0021-9258(18)95800-X","article-title":"Esterase activities of human carbonic anhydrases B and C","volume":"242","author":"Verpoorte","year":"1967","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0335","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.bioorg.2019.02.008","article-title":"Investigation of inhibitory properties of some hydrazone compounds on hCA I, hCA II and AChE enzymes","volume":"86","author":"Kucukoglu","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104554_b0340","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2020.104554_b0345","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.molstruc.2018.11.038","article-title":"Imidazolinium chloride salts bearing wingtip groups: Synthesis, molecular docking and metabolic enzymes inhibition","volume":"1179","author":"Yi\u011fit","year":"2019","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2020.104554_b0350","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/bmc.2761","article-title":"Rapid screening and identification of \u03b1-glucosidase inhibitors from mulberry leaves using enzyme-immobilized magnetic beads coupled with HPLC\/MS and NMR","volume":"27","author":"Tao","year":"2013","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.bioorg.2020.104554_b0355","doi-asserted-by":"crossref","first-page":"1800263","DOI":"10.1002\/ardp.201800263","article-title":"Antidiabetic potential: in vitro inhibition effects of bromophenol and diarylmethanones derivatives on metabolic enzymes","volume":"351","author":"Demir","year":"2018","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2020.104554_b0360","unstructured":"S. Release, 2: LigPrep, Schr\u00f6dinger, LLC, New York, NY, 2017, New York, NY, 2017."},{"key":"10.1016\/j.bioorg.2020.104554_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.127868","article-title":"Synthesis of novel organohalogen chalcone derivatives and screening of their molecular docking study and some enzymes inhibition effects","volume":"1208","author":"Burmaoglu","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2020.104554_b0370","unstructured":"QikProp, Schr\u00f6dinger, LLC, New York, NY, 2020."},{"key":"10.1016\/j.bioorg.2020.104554_b0375","series-title":"Schr\u00f6dinger","author":"Epik","year":"2016"},{"key":"10.1016\/j.bioorg.2020.104554_b0380","unstructured":"Impact, Schr\u00f6dinger, LLC, New York, NY, 2016."},{"key":"10.1016\/j.bioorg.2020.104554_b0385","unstructured":"Prime, Schr\u00f6dinger, LLC, New York, NY, 2020."},{"key":"10.1016\/j.bioorg.2020.104554_b0390","first-page":"1","article-title":"A study on the effects of inhibition mechanism of curcumin, quercetin, and resveratrol on human glutathione reductase through in vitro and in silico approaches","author":"G\u00fcller","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2020.104554_b0395","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22421","article-title":"In vitro effects of standard antioxidants on lactoperoxidase enzyme\u2013A molecular docking approach","volume":"34","author":"Kalin","year":"2020","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bioorg.2020.104554_b0400","unstructured":"Glide, Induced Fit Docking Protocol; Schr\u00f6dinger, LLC, New York, NY, 2016."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820318526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820318526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:09:51Z","timestamp":1758614991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206820318526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":80,"alternative-id":["S0045206820318526"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104554","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Probing 4-(diethylamino)-salicylaldehyde-based thiosemicarbazones as multi-target directed ligands against cholinesterases, carbonic anhydrases and \u03b1-glycosidase enzymes","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104554","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104554"}}